Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 2241 filtered startups

Propely AS

Propely er et ungt og nytenkende tech-selskap som leverer revolusjonerende programvare til eiendomsbransjen. Vi skiller oss ut ved å levere en sømløs plattform for kommunikasjon mellom utleiere, leietakere og leverandører, en plattform som gir en bedre og mer effektiv drift av eiendommer, samt mer fornøyde brukere av byggene.

QuizzWizz AS

We are currently developing a platform for creating, playing and selling quizzes.A web platform where everybody can create quizzes in many different shapes and sizes. A vault where quiz creators can get access to a huge amount to ready to use questions and answers.An APP for playing quizzes, in the classic way and in ways you did not know was possible.And maybe the most important, at marketplace where creators can publish quizzes and earn money. Like Google Play and Appstore, but just for Quizzes.

Med-Storm GO

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

Tigeni AS

We are simplifying personal health control, by making clinically proven testing readily available to the public. Tigeni is a healthcare and technology company that makes blood screening convenient, safe and monitorable in a simple, personal and secure health dashboard. Tigeni offers at-home-finger-prick-test, monitoring and test results with professional lifestyle guidance, accessible on PC and mobile. Through innovation, information and motivation, we are empowering our customers to take control of their health and live better lives.

Fjordmail Technologies

You are not a product. Why let your inbox be sold to advertisers? Fjordmail is your private, secure, and green email service. Fjordmail aims to offer the following:-- Secure and privacy-aware email service with a modern and easy-to-use interface-- Take full control of your inbox and say goodbye to spam through pre-qualification of senders-- One-click access to add additional encryption for sensitive emails-- Protection by strict Norwegian privacy law in addition to EU legislation. Our first customers have already joined Fjordmail with our "minimal viable product" which is already in the market. Our addressable segment of the email market is growing by 40-60% p.a.Click here to find out more about Fjordmail

Rada Labs

Rada Labs are bringing app ideas to life. With a big focus on creativity and innovation the company develop never seen before applications for smartphones, tablets, smart watches and computers. Rada Labs consists of creative people who love to develop high quality products and services. With innovation in focus, we develop our own brands within apps as well as develop applications for our customers. We build apps for smartphones, smartwatches, tablets and computers. By using tailored innovation processes and the latest technology in cloud services, machine learning and artificial intelligence, we can create smart applications that reach all target groups!

Radiocraft

Radiocrafts is a leading RF module design and manufacturing company. Radiocrafts’ standard RF modules provide compact, easy-to-use, low cost, low power and high performance RF solutions for a large number of wireless applications using license-free ISM bands. By using modules OEM manufacturers without RF design knowledge can easily add wireless technology into their design, reducing time-to-market, cost of design, test, and compliance approvals. Radiocrafts also offers custom and application-specific product development, supporting customers from initial project ideas to volume product delivery. Radiocrafts currently provides solutions in the frequency bands 169, 433, 868, 915, and 2450 MHz, supporting radio protocols such as Wireless M-Bus, KNX, ZigBee, 6LoWPAN, SIGFOX, WIZE as well as proprietary solutions such as TinyMesh, RC232, and now our newest product lines, RIIoT and RIIM.

Upnorth Ventures

UpNorth Ventures was formed in 2017 by a team of experienced entrepreneurs/executives with broad business, financial, tech and entrepreneurial backgrounds. The team is supported by a network of tech resources and other. We are growing, and currently looking for new partners and employees. We believe in building companies from scratch with a bootstrap mentality that makes them profitable early on. Are you an entrepreneur, investor or just curious, then let us know at hello@upnorth.vc

Grasp AS

Grasp Your Future Our goal is to increase effectiveness and efficiency of medical treatments through person-centered care and improved clinician-patient communication. Grasp concept One-minute video presenting how Grasp works. Grasp Tracker A patented, CE-marked, and approved medical device. You simply squeeze the device when tracking your symptoms, behavior, and events. Grasp User app Through the user app, the doctor is connected to the patient´s everyday life in real-time: at home, at work, or while engaging in activities. Grasp Clinical solution The doctor can remotely and easily adjust the treatment, modify medical plans or give tailored behavioral feedback to increase the function of the patient

Norwegian eye AS

Kom tett på! Ønsker du å være tett på naturen året rundt, og oppleve ditt favorittsted i solskinn, når høststormen blåser eller regnet høljer ned? Med en gjennomsiktig iglo har du trehundreogseksti graders utsikt til fjell, skog og hav – uansett vær! En Norwegian Eye iglo er unik og har mange bruksområder: overnatting ute, store og små happenings, et sted for de gode samtalene, eller nyte en bedre middag i godt selskap. Veggene er laget av et utrolig sterkt, gjennomsiktig materiale. Igloen kommer med et spesialbygget, isolert gulv og døren er låsbar. Konstruksjonen består av moduler, noe som gjør den lett flyttbar. Likevel står den stabilt og trygt året rundt. Så tøff at den står imot troll og uvær! Til tross for kun 5 mm uknuselig skille mellom ute og inne, gjør gode oppvarmings- og ventilasjonsløsninger det komfortabelt. Panel-, gass- eller vedovn, samt kjøle- og varmepumpe er gode løsninger for å gjøre det behagelig inne. Om skjerming for innsyn er viktig, er det bare å trekke opp rullegardinene. Øvrig innredning skaper et personlig sted. En investering i Norwegian Eye igloen er enkelt med utgangspunkt i våre skreddersydde finansieringsløsninger. Opplevelser uansett vær. Tett på naturen! Trehundreogsekstigraders utsikt!

Mesier AS

Gain visibility and control over your compliance processes with ease! Our integrated GDPR solution includes consent management, data discovery, documentation, audit logs, assessments, people and customer profiles, and much more. We give you a practical approach to GDPR and "Privacy by design". Get also an award-winning access portal that supports secure Single Sign-On access of data and easy setup of security policies. Mesier, The holistic approach to Cloud governance! Currently, we are 10 highly motivated people with extensive experience in making successful software. Let's talk!

GRIN

We make smart collection systems for the circular economy. Helping companies get their circular products back from consumers. So that the products can be reused, refurbished or recycled. Think reverse vending machines for bottles and cans- but for other products, and with a twist of cutting edge technology and beautiful design. We’re an early phase start-up based in Oslo, collaborating with some of the largest companies in the world, helping them transition from linear to circular. We are located at StartupLab at Oslo Science Park, the epicentre of Norway’s tech start-up scene. As part of the GRIN team, you will be given the opportunity to shape and scale a company, as well as innovating, developing, and growing new global business models necessary for a sustainable future.

Pharmasum Therapeutics AS

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Mitta AS

Think Outside is now Mitta AS, a subsidiary fully owned by Mitta Oy. Mitta will be offering geodata monitoring and measurement services to the Norwegian market, bridging the growth of the Finnish and Swedish Mitta companies to new Norwegian customers. For us at Mitta, accurate and reliable positioning is extremely important, as it is a basic prerequisite for spatial information. High-quality input data means cost-effectiveness in design, construction and monitoring, regardless of the customer's industry. Mitta is the market leader as a producer and processor of terrain information in the infrastructure sector in Finland and Sweden. Our customers operate in the construction value chain from design to production.

Oxy Solutions AS

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.